Results 241 to 250 of about 42,260 (251)

Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent

Nature Medicine, 2006
Lisia Esper, Andre Bafica, Charles N Serhan   +2 more
exaly  

Aspirin as adjuvant therapy for colorectal cancer—reinterpreting paradigms

Nature Reviews Clinical Oncology, 2012
Raghib Ali
exaly  

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

Lancet, The, 2011
Peter M Rothwell
exaly  

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

Lancet, The, 2007
Jonathan Mant, Fd Richard Hobbs, Gregory Lip   +2 more
exaly  

Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials

Lancet, The, 2012
Peter M Rothwell
exaly  

Daily aspirin may reduce mortality from prostate cancer with risk of high recurrence

Ca-A Cancer Journal for Clinicians, 2015
exaly  

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

Lancet, The, 2018
Stuart J Connolly, John W. Eikelboom, Jackie J Bosch   +2 more
exaly  

Opioid analgesics for nociceptive cancer pain: A comprehensive review

Ca-A Cancer Journal for Clinicians
Christina Abdel Shaheed, Chris Hayes, Chris G Maher   +2 more
exaly  

Potential cardioprotective actions of no-releasing aspirin

Nature Reviews Drug Discovery, 2002
John L Wallace, Stefano Fiorucci
exaly  

Daily aspirin reduces colorectal cancer incidence in patients with Lynch syndrome

Ca-A Cancer Journal for Clinicians, 2012
exaly